menu search

Astrazeneca's covid-19 therapy hits goal in phase 3 trial

AstraZeneca Plc (NASDAQ: AZN) released top-line data from the TACKLE Phase 3 trial in which its experimental COVID-19 drug has helped cut the risk ...

October 11, 2021, 1:33 pm

Astrazeneca's covid-19 therapy hits goal in phase 3 trial

AstraZeneca Plc (NASDAQ: AZN) released top-line data from the TACKLE Phase 3 trial in which its experimental COVID-19 drug has helped cut the risk ...

October 11, 2021, 1:33 pm

Astrazeneca's covid-19 therapy hits goal in phase 3 trial

AstraZeneca Plc (NASDAQ: AZN) released top-line data from the TACKLE Phase 3 trial in which its experimental COVID-19 drug has helped cut the risk ...

October 11, 2021, 1:33 pm

Merck seeks u.s. emergency approval for antiviral covid pill

A late-stage trial showed the pill, which Merck is developing with Miami-based Ridgeback Therapeutics, halves the chances of hospitalization or death ...

October 11, 2021, 6:36 am

Merck seeks u.s. emergency approval for antiviral covid pill

A late-stage trial showed the pill, which Merck is developing with Miami-based Ridgeback Therapeutics, halves the chances of hospitalization or death ...

October 11, 2021, 6:36 am

Merck seeks u.s. emergency approval for antiviral covid pill

A late-stage trial showed the pill, which Merck is developing with Miami-based Ridgeback Therapeutics, halves the chances of hospitalization or death ...

October 11, 2021, 6:36 am

Astrazeneca says drug cocktail effective in reducing risk of developing severe covid-19

AstraZeneca says its experimental antibody drug cocktail can reduce the risk by 50% in patients who had been symptomatic for less than seven days....

October 11, 2021, 6:22 am

Astrazeneca says drug cocktail effective in reducing risk of developing severe covid-19

AstraZeneca says its experimental antibody drug cocktail can reduce the risk by 50% in patients who had been symptomatic for less than seven days....

October 11, 2021, 6:22 am

Astrazeneca says drug cocktail effective in reducing risk of developing severe covid-19

AstraZeneca says its experimental antibody drug cocktail can reduce the risk by 50% in patients who had been symptomatic for less than seven days....

October 11, 2021, 6:22 am

Merck files for emergency authorization of covid-19-treating pill

Merck & Co. Inc. MRK, -1.60% and Ridgeback Biotherapeutics said Monday that Merck has submitted an application for Emergency Use Authorization (EUA) w...

October 11, 2021, 6:14 am

Merck files for emergency authorization of covid-19-treating pill

Merck & Co. Inc. MRK, -1.60% and Ridgeback Biotherapeutics said Monday that Merck has submitted an application for Emergency Use Authorization (EUA) w...

October 11, 2021, 6:14 am

Merck files for emergency authorization of covid-19-treating pill

Merck & Co. Inc. MRK, -1.60% and Ridgeback Biotherapeutics said Monday that Merck has submitted an application for Emergency Use Authorization (EUA) w...

October 11, 2021, 6:14 am

Astrazeneca's injectable antibody cocktail halves risk of death or developing severe covid, trial finds

The British pharma firm has already asked U.S. regulators for emergency approval to use the antibody cocktail to prevent symptomatic Covid-19....

October 11, 2021, 5:53 am

Astrazeneca's injectable antibody cocktail halves risk of death or developing severe covid, trial finds

The British pharma firm has already asked U.S. regulators for emergency approval to use the antibody cocktail to prevent symptomatic Covid-19....

October 11, 2021, 5:53 am

Astrazeneca's injectable antibody cocktail halves risk of death or developing severe covid, trial finds

The British pharma firm has already asked U.S. regulators for emergency approval to use the antibody cocktail to prevent symptomatic Covid-19....

October 11, 2021, 5:53 am

Astrazeneca antibody treatment halves covid-19 deaths in new trial

AstraZeneca's new long- acting antibody (LAAB) treatment halved the risk of death or catching severe Co...

October 11, 2021, 2:51 am

Astrazeneca antibody treatment halves covid-19 deaths in new trial

AstraZeneca's new long- acting antibody (LAAB) treatment halved the risk of death or catching severe Co...

October 11, 2021, 2:51 am

Astrazeneca antibody treatment halves covid-19 deaths in new trial

AstraZeneca's new long- acting antibody (LAAB) treatment halved the risk of death or catching severe Co...

October 11, 2021, 2:51 am


Search within

Pages Search Results: